ycliper

Популярное

Музыка Кино и Анимация Автомобили Животные Спорт Путешествия Игры Юмор

Интересные видео

2025 Сериалы Трейлеры Новости Как сделать Видеоуроки Diy своими руками

Топ запросов

смотреть а4 schoolboy runaway турецкий сериал смотреть мультфильмы эдисон
Скачать

The Biomarker Qualification Process: A Roadmap for Requestors

Автор: U.S. Food and Drug Administration

Загружено: 2017-09-15

Просмотров: 3029

Описание: Marianne Noone, RN, from FDA’s Center for Drug Evaluation and Research (CDER), describes the biomarker qualification process and the submission roadmap for biomarker qualification requestors. The process for biomarker qualification was modified in response to the 21st Century Cures Act passed in 2016. This module is an introductory guide through the updated process, which contains three submission stages: the Letter of Intent, the Qualification Plan, and the Full Qualification Package.
Learn more about FDA’s Biomarker Qualification Program at http://www.fda.gov/biomarkerqualifica....

Не удается загрузить Youtube-плеер. Проверьте блокировку Youtube в вашей сети.
Повторяем попытку...
The Biomarker Qualification Process: A Roadmap for Requestors

Поделиться в:

Доступные форматы для скачивания:

Скачать видео

  • Информация по загрузке:

Скачать аудио

Похожие видео

A Closer Look at Context of Use

A Closer Look at Context of Use

Medical Device Quality Management System Regulation Risk Management

Medical Device Quality Management System Regulation Risk Management

Public Meeting: Reauthorization of the Biosimilar User Fee Act

Public Meeting: Reauthorization of the Biosimilar User Fee Act

What Does Biomarker Qualification Do (And Not Do)?

What Does Biomarker Qualification Do (And Not Do)?

GCP & Pharmacovigilance Compliance Symposium | D3S03-1 - (BE): Clinical Study Conduct

GCP & Pharmacovigilance Compliance Symposium | D3S03-1 - (BE): Clinical Study Conduct

FDA Expert Panel on Testosterone Replacement Therapy for Men

FDA Expert Panel on Testosterone Replacement Therapy for Men

GCP & Pharmacovigilance Compliance Symposium | D2S06 – Panel Discussion

GCP & Pharmacovigilance Compliance Symposium | D2S06 – Panel Discussion

Conversations on Cancer – Perspectives on Cancer Care Decision-Making Among Older Adults

Conversations on Cancer – Perspectives on Cancer Care Decision-Making Among Older Adults

Tobacco Products Scientific Advisory Committee Meeting, October 7, 2025

Tobacco Products Scientific Advisory Committee Meeting, October 7, 2025

What Do You Need to Consider When Qualifying a Biomarker?

What Do You Need to Consider When Qualifying a Biomarker?

Good Clinical Practice & Pharmacovigilance Compliance Symposium | D3S05 - (PV): Future of...

Good Clinical Practice & Pharmacovigilance Compliance Symposium | D3S05 - (PV): Future of...

Initiating the Removal of the “Black Box Warning” on Hormone Replacement Therapy

Initiating the Removal of the “Black Box Warning” on Hormone Replacement Therapy

Making Biomarker Development Successful

Making Biomarker Development Successful

Medical Device Quality Management System Regulation Design and Development

Medical Device Quality Management System Regulation Design and Development

November 13, 2025: Pediatric Advisory Committee Meeting (PAC)

November 13, 2025: Pediatric Advisory Committee Meeting (PAC)

FDA Direct: Removing Black Box Warnings for HRT (Part 1/2)

FDA Direct: Removing Black Box Warnings for HRT (Part 1/2)

Good Clinical Practice & Pharmacovigilance Compliance Symposium | D3S06 - (PV): Regulatory Updates

Good Clinical Practice & Pharmacovigilance Compliance Symposium | D3S06 - (PV): Regulatory Updates

Kathryn Aikin, Ph.D.

Kathryn Aikin, Ph.D.

Good Clinical Practice & Pharmacovigilance Compliance Symposium | D3S03-2 – Q&A Discussion Panel

Good Clinical Practice & Pharmacovigilance Compliance Symposium | D3S03-2 – Q&A Discussion Panel

FDA Direct: Catching Up on Agency Reforms

FDA Direct: Catching Up on Agency Reforms

© 2025 ycliper. Все права защищены.



  • Контакты
  • О нас
  • Политика конфиденциальности



Контакты для правообладателей: [email protected]